Does SECUKINUMAB Cause Obesity? 1,333 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,333 reports of Obesity have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.9% of all adverse event reports for SECUKINUMAB.
1,333
Reports of Obesity with SECUKINUMAB
0.9%
of all SECUKINUMAB reports
1,023
Deaths
1,147
Hospitalizations
How Dangerous Is Obesity From SECUKINUMAB?
Of the 1,333 reports, 1,023 (76.7%) resulted in death, 1,147 (86.0%) required hospitalization, and 1,059 (79.4%) were considered life-threatening.
Is Obesity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 1,333 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Obesity?
RISPERIDONE (3,039)
PREDNISONE (1,880)
METHOTREXATE (1,876)
ADALIMUMAB (1,780)
TOCILIZUMAB (1,630)
ABATACEPT (1,605)
INFLIXIMAB (1,536)
HYDROXYCHLOROQUINE (1,532)
SULFASALAZINE (1,455)
ETANERCEPT (1,407)
Which SECUKINUMAB Alternatives Have Lower Obesity Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG